Skip to content

HALSTED HAMPTON

Active
Private limited companyfounded 2021active for 5 yearsQuellinstraat 1, 2018 Antwerpen, BelgiumKBO/BCE: BE 0762.817.106
Summary

The computed 12-month bankruptcy probability of HALSTED HAMPTON is 4.2% (elevated). The 2024 annual accounts show equity of €187,939 and a net result of -€160,130. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 65% of 15,490 sector peers (NACE 46, financial year 2024). The company has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals.

Overview

Activity
Wholesale of pharmaceutical and medical goods
NACE 46460
1 site
Size
€325,786total assets 2024
Staff
1.8 FTE
Equity
€187,939
Loss
-€160,130
Turnover not published (micro format)
Financial health
47 Fair Checked score 2024
Bankruptcy probabilitywithin 12 months
4.2%
Structure
Largest shareholder
SOLFAY GROUP · 22.05%
Accounts 72 days overdue0 of 4 deeds read
Why 47raises riskFigures for financial year 2024 (filed 29-08-2025)Liquidity: current ratio 2.25, cash €4, halved1 financial year not filed after the legal deadline; latest accounts 29 days latelowers riskSize: total assets €325,786Show the evidence

Checked score

Score 2024
47 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially better than 27% of its sector peers (NACE 46, micro)
Financial strength · tick = 2023
Weak
Solvency 83+3
equity 57.7% of total assets
Liquidity 30-1
short-term debt 42.3% · cash 0.0%
Profitability 0=
return on assets -49.2%
Bankruptcy probability, 12 months
4.2% Elevated
0%0.5%1.5%4%10%≥ 25%

About 4 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.4% (26,870 companies, NACE 46, micro)
Last 24 months 11-2024: 2.5% 12-2024: 2.5%● unchanged vs 11-2024 01-2025: 2.5%● unchanged vs 12-2024 02-2025: 2.5%● unchanged vs 01-2025 03-2025: 2.4%▼ -0.1 percentage points vs 02-2025 04-2025: 3.0%▲ +0.6 percentage points vs 03-2025 05-2025: 3.2%▲ +0.2 percentage points vs 04-2025 06-2025: 3.6%▲ +0.4 percentage points vs 05-2025 07-2025: 3.7%▲ +0.1 percentage points vs 06-2025 08-2025: 4.2%▲ +0.5 percentage points vs 07-2025 09-2025: 3.7%▼ -0.5 percentage points vs 08-2025 10-2025: 3.7%● unchanged vs 09-2025 11-2025: 3.7%● unchanged vs 10-2025 12-2025: 3.7%● unchanged vs 11-2025 01-2026: 3.6%▼ -0.1 percentage points vs 12-2025 02-2026: 3.7%▲ +0.1 percentage points vs 01-2026 03-2026: 3.6%▼ -0.1 percentage points vs 02-2026 04-2026: 3.9%▲ +0.3 percentage points vs 03-2026 05-2026: 4.0%▲ +0.1 percentage points vs 04-2026 06-2026: 4.1%▲ +0.1 percentage points vs 05-2026 07-2026: 4.1%● unchanged vs 06-2026 08-2026: 2.3%▼ -1.8 percentage points vs 07-2026lowest value 09-2026: 2.6%▲ +0.3 percentage points vs 08-2026 10-2026: 4.2%▲ +1.6 percentage points vs 09-2026highest value
Credit of up to €8,000 on 30-day terms, only on tighter conditions
Liquidity ample (current ratio 2.25, compared with 2.19 in 2023; short-term debt: 42.3% and cash: 0% of total assets), and 42.3% of the assets are financed with debt.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, micro): better than 64% on solvency, 27% on liquidity, 6% on profitability and 11% on growth.

The bankruptcy probability was computed on 10-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
raises risk · Figures for financial year 2024 (filed 29-08-2025)
NBB · annual accounts
raises risk · Liquidity: current ratio 2.25, cash €4, halved
NBB · annual accounts
raises risk · 1 financial year not filed after the legal deadline; latest accounts 29 days late
NBB · filings
lowers risk · Size: total assets €325,786
The company's size counts in the probability; how much depends on the rest of its profile.
NBB · annual accounts
raises risk · Persistent losses
Two consecutive loss-making years (2023 and 2024); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2024
Net result per financial year
21222324
2021 to 2024 · latest year -€160,130
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 29-08-2025, 29 days later. For context: 47% of Belgian companies file late, and of those that file 1 to 90 days late, 2.0% are now in a legal situation other than normal in the KBO (such as bankruptcy, liquidation or dissolution), against 1.66% of all filers. We show this as a fact and do not score it.
NBB · 4 filings
Deviation from the deadline
2025
not confirmed
2024
29 days late
2023
134 days early
2022
11 days early
2021
80 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 4 accounts on average 9 days before the deadline; the sector median (NACE 46) for financial year 2024 is 3 days before the deadline, and 39% of those companies filed late.

Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2024 · micro…
  2. Annual accounts filedfinancial year 2023 · micro…
  3. Liquidity more than 5 timescurrent ratio 2.19

Key points

  • Risk: 4 loss-making years in a rowloss financial year 2024 -€160,130 View
  • Caution: Among the weakest 5% on net resultsector median €4,915 · 15,473 companies -€160,130 View
  • Caution: Accounts not fileddeadline was 31-07-2026 72 days late View
  • Caution: Equity fell in 2024from €348,069 to €187,939 ▼ 46.0% View
  • Flemish supportawarded 2024 - 2025 €50,000 View

By topic

Financials

Financial year
2024
Total assets
€325,786
Loss
-€160,130
Solvency
57.7%
Total assets▼ 49.0%
Net result
20212024
Go to Financials

Timeline

Events
7
Since
2022
  1. 31-12-2023Equity above €200,000
  2. 20-07-2023Annual accounts filed
  3. 31-12-2022Weakest financial year
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460
Founded
02-02-2021
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.